Showing results (401-410 of 436) with videos related to

Sort By:
Pageof 44
Haematologica|September 5, 2024
Loncastuximab tesirine in Chinese patients with relapsed or refractory diffuse large B-cell lymphoma: a multicenter, open-label, single-arm, phase II trialNingjing Lin, Xiuhua Sun, Hui Zhou, et al.
Frontiers in Immunology|February 18, 2026
Immunoglobulin NGS enhance residual disease detection and prognosis in pediatric Ph+ acute lymphoblastic leukemiaLixian Chang, Jiao Chang, Beibei Zhao, et al.
Nature Computational Science|January 4, 2024
Dynamic forecasting of severe acute graft-versus-host disease after transplantationXueou Liu, Yigeng Cao, Ye Guo, et al.
Journal of Hematology & Oncology|September 7, 2020
Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemiaRunxia Gu, Fang Liu, Dehui Zou, et al.
Oral Oncology|December 15, 2023
Clinical decision pathway and management of locally advanced head and neck squamous cell carcinoma: A multidisciplinary consensus in Asia-PacificYe Guo, Torahiko Nakashima, Byoung Chul Cho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2023
Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II StudyHuiqiang Huang, Rong Tao, Siguo Hao, et al.
Med (New York, N.Y.)|February 20, 2026
Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trialFei Han, Xing Lv, Yu-Juan Zhou, et al.
The Lancet. Oncology|June 1, 2024
BL-B01D1, a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 studyYuxiang Ma, Yan Huang, Yuanyuan Zhao, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 7, 2020
[The Correlation of Minimal Residual Disease with Prognosis in TCF3-PBX1<sup>+</sup> Acute Lymphoblastic Leukemia in Children]Li Zhang, Yao Zou, Xiao-Fei Ai, et al.
Nature Cell Biology|February 11, 2022
Elucidating minimal residual disease of paediatric B-cell acute lymphoblastic leukaemia by single-cell analysisYingchi Zhang, Shicheng Wang, Jingliao Zhang, et al.
Pageof 44